Borrowing base loans are common in healthcare, but the real constraint on liquidity is often reserves, not the advance rate. Reserves are risk-based deductions that quietly reduce how much a company can borrow, and in healthcare they tend to be larger and more frequent because reimbursement and reporting are complex.
One major driver is how healthcare receivables behave. Insurance claims are often reduced by denials, discounts, and patient responsibility. If these reductions aren’t clearly reflected in reports, lenders may view the receivables as riskier than they are and apply extra reserves—even when collections are solid.
Reporting timing also causes issues. Borrowing bases are calculated as of a specific date, but billing systems update continuously. If reports don’t match cutoff dates or reconcile cleanly to the general ledger, lenders may question data reliability and add reserves until reporting improves.
Payor concentration is another common trigger. Heavy reliance on a single insurer or government program can exceed concentration limits in a borrowing base formula and lead to reserves or ineligibles, even if that payor is financially stable. Because healthcare borrowing bases are typically driven almost entirely by accounts receivable, these concentration issues can have an outsized impact on availability and create unexpected borrowing base pressure.
Loan eligibility rules add further risk. Some receivables that look fine internally, such as disputed or recoupment-prone balances, may be ineligible under the credit agreement. When these are included in reporting, lenders typically correct through reserves, reducing availability.
Reserves can also be driven by performance trends, not just collateral quality. Rising days sales outstanding, slower collections, or covenant pressure may automatically tighten borrowing capacity, even if the business remains fundamentally sound.
Healthcare companies that avoid surprises tend to have strong reporting processes, clear documentation, and open communication with lenders. Staying ahead of dilution, concentration, and eligibility issues helps protect liquidity and prevents technical missteps from becoming real cash flow problems.
